Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members...
Nutrition
Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages
Company to Launch AI Food & Recipe App to Access Trillion-Dollar Global Food Market While Advancing Medical AI Pipeline MESA,...
Adia Nutrition Inc. Announces IRB Approval from BeyondBound for Adia Med’s Autism Clinical Study
Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through...
Adia Nutrition Inc. Announces IRB Approval from BeyondBound for Adia Med’s Autism Clinical Study
Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through...
Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
SBS-IF is the second orphan disease target indication for Jaguar's intestinal failure program, which includes microvillus inclusion disease (MVID) -...
Healthcare IT Market Set to More Than Double by 2030 Growing at 15.24% CAGR, Reports Mordor Intelligence
HYDERABAD, India, December 15, 2025 /PRNewswire/ -- According to Mordor Intelligence, the healthcare IT market is valued at USD 413.14...
Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care
LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight management has undergone a seismic...
Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization
ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on...
PatchMD Launches New Dopamine Support Patch for Natural Mood and Focus Support
Original Vitamin Patch Pioneer Introduces Comprehensive Dopamine Precursor Formula Backed by Clinical ResearchLas Vegas, NV, Dec. 11, 2025 (GLOBE NEWSWIRE)...
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or...
Stellar Health and CenterLight Healthcare Announce Partnership to Enable Providers And Improve Health Outcomes for New York Seniors
NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Stellar Health, a healthcare technology company focused on revolutionizing value-based care, today announced...
New Research from Shed Reveals How Americans Are Really Trying to Lose Weight
From intermittent fasting to GLP-1s, Americans are rethinking how they lose weight—and what "healthy" really looks likeSALT LAKE CITY, Dec....
Aeroflow Health and Molina Healthcare Break Down Barriers to Nutrition and Diabetes Care in South Carolina
The new partnership expands nutrition counseling and DSME services for Molina Commercial and Medicare members statewide to support long-term health...
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq:...
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq:...
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
VTP-1000, an antigen-specific immunotherapy to treat celiac disease, showed a dose-dependent pharmacological effect in the SAD portion of the trialVTP-1000...
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
VTP-1000, an antigen-specific immunotherapy to treat celiac disease, showed a dose-dependent pharmacological effect in the SAD portion of the trialVTP-1000...
Qualia Life Sciences, Award-Winning Supplement Brand, Celebrates Its 10th Year Anniversary
With Human Studies On Every Formula, Qualia's Industry-Leading Research Standards Are Fueling Innovation and Rapid GrowthCARLSBAD, Calif., Dec. 9, 2025...
Fitasy Unveils Breakthrough Technology Making Custom-Fit 3D Printed Shoes More Accessible and Affordable, Supporting Better Foot Health
Fitasy is set to transform the footwear industry with new technology that democratizes access to custom-fit shoes—improving comfort, reducing waste,...
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA’s DNA-Guided Biofeedback Wellness Ecosystem
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and...